Galangin inhibits glioma migration and invasion through suppressing transforming growth factor .BETA.
Lists
Only you see this
Abstract
Objective To investigate the effect of Galangin on migration and invasion in gliomas and explore the possible mechanism. Methods (1) After treating the glioma lines U87 and U251 with 0, 10, 20 and 40 μmol/L galangin for 24 h, CCK-8 was performed to detect the cell viability; wound healing assay and Transwell assay were used to detect the cell migration and invasion, respectively; protein expression of transforming growth factor (TGF) β was detected by Western blotting. (2) The second experiment was divided into control group, 20 μmol/L galangin treatment group, TGFβ over-expression group and 20 μmol/L galangin+TGFβ over-expression group; the cells in the control group and 20 μmol/L galangin treatment group were transfected with empty-vector plasmids; cells in the TGFβ over-expression group and 20 μmol/L galangin+TGFβ over-expression group were transfected with TGFβ plasmids, and 24 h after the transfection, the cells in the 20 μmol/L galangin treatment group and 20 μmol/L galangin+TGFβ over-expression group were added 20 μmol/L galangin; 24 h after that, wound healing assay and Transwell assay were used to detect the cell migration and invasion, respectively; TGF β protein expression was detected by Western blotting. Results (1) As compared with cells from the 0, 10 and 20 μmol/L galangin group, the cells from 40 μmol/L galangin group had significantly lower cell viability (P<0.05). Cells from the 0, 10 and 20 μmol/L galangin group had significantly decreased wound healing percentage, significantly decreased cell number reaching to the lower chamber, and statistically decreased TGFβ protein expression in sequence (P<0.05). (2) U87 and U251 cells from the TGFβ over-expression group, control group, 20 μmol/L galangin+TGFβ over-expression group and 20 μmol/L galangin treatment group had successively decreased wound healing percentage, decreased cell number reaching to the lower chamber, and decreased TGFβ protein expression (U87 cells: 1.63±0.21, 1.00±0.00, 0.78±0.05 and 0.43±0.08; U251 cells: 1.98±0.20, 1.00±0.00, 0.86±0.06 and 0.29±0.04), with significant differences (P<0.05). Conclusion Galangin inhibits the glioma migration and invasion through TGFbβ down-regulation. Key words: Galangin; Migration; Invasion; Transforming growth factor β
BibTeX
@inproceedings{xiong2016galangin,
author = {Yu Xiong and Jie Zhou and Hao Li and Lilei Peng and Lai Xue and Ming Yang and Ligang Chen},
title = {{Galangin inhibits glioma migration and invasion through suppressing transforming growth factor .BETA.}},
booktitle = {Chinese},
year = {2016},
doi = {10.3760/cma.j.issn.1671-8925.2016.09.002},
}Loading related content...